{"data":{"responsecode":"000","responsemsg":"","quote":{"hi":"","rs_stock_flag":false,"fiscal_year_end":"","hist_closedate":"","replication_method":null,"amt_os":"302,223,586","primaryexch":"HKEX","ric":"2652.HK","product_subtype":null,"db_updatetime":"07 Oct 2025 09:36","mkt_cap_u":"","am_u":"","ew_sub_right":"","secondary_listing":false,"ew_amt_os_cur":null,"ccy":"HKD","management_fee":"","ew_underlying_code":null,"trdstatus":"N","nav":"","original_offer_price":"","issue":"","asset_class":null,"eps":null,"inline_upper_strike_price":"","sedol":"BW61YN1","am":"","iv":"","ew_strike":"","as":"","geographic_focus":null,"incorpin":"PRC","etp_baseCur":null,"ew_amt_os":"","bd":"","registrar":"Computershare Hong Kong Investor Services Ltd.","depositary":null,"exotic_type":null,"callput_indicator":null,"primary_market":null,"underlying_index":null,"lot":"500","update_time":"2025-10-07 01:36:25.0","lo52":"","shares_issued_date":"8 Oct 2025","premium":"","strike_price_ccy":null,"yield":"","vo_u":"","base_currency":null,"coupon":"","expiry_date":"","chairman":"Liang Bill Wenqing","underlying_ric":"2652.HK","hi52":"","issuer_name":"CF PharmTech, Inc. - H Shares","h_share_flag":false,"ew_sub_per_from":"","div_yield":"","interest_payment_date":"-","updatetime":"","aum_date":"","lo":"","mkt_cap":"","f_aum_hkd":null,"ew_sub_per_to":"","ls":"","nav_date":"","csic_classification":null,"floating_flag":false,"issued_shares_note":null,"nom_ccy":null,"eff_gear":"","board_lot_nominal":null,"hsic_ind_classification":"Healthcare - Pharmaceuticals & Biotechnology","ew_desc":null,"inception_date":"","nc":"","aum":"","issued_shares_class_B":null,"vo":"","secondary_listing_flag":false,"listing_date":"8 Oct 2025","issued_shares_class_A":null,"as_at_label":"as at","ew_amt_os_dat":"","nm":"CF PharmTech, Inc. - H Shares","nm_s":"CF PHARMTECH","sym":"2652","inline_lower_strike_price":"","listing_category":"Primary Listing","ew_strike_cur":null,"exotic_warrant_indicator":null,"investment_focus":null,"call_price":"","tck":"","strike_price":"","summary":"CF PharmTech Inc is a China-based company primarily focused on the research & development, manufacturing and commercialization of inhalation technologies and inhalation drugs. The Companyâ€™s product portfolio primarily focused on respiratory diseases, including asthma, chronic obstructive pulmonary disease (COPD) and allergic rhinitis. The Company's primary products include CF017, a budesonide suspension for inhalation targeting bronchial asthma, and CF018, an azelastine hydrochloride and fluticasone propionate nasal spray approved for allergic rhinitis.","op":"","aum_u":"","nav_ccy":null,"class_B_description":null,"os":"","wnt_gear":"","transfer_of_listing_date":"","hsic_sub_sector_classification":"Pharmaceuticals","amt_ccy":null,"class_A_description":null,"domicile_country":null,"entitlement_ratio":"","product_type":"EQTY","office_address":"No. 16, Hucundang Road<br/>Xiangcheng Economic<br/>Development District<br/>Suzhou, Jiangsu, PRC","pc":"","days_to_expiry":null,"underlying_code":null,"pe":"","eps_ccy":null,"hdr":false,"launch_date":"","hc":"","isin":"CNE1000074R9","moneyness":""}},"qid":"1759804232720"}
